What causes nf2

Overview

Neurofibromatosis type 2 (NF2) is a rare genetic disorder that is characterized by the development of tumors on nerve tissue. These tumors are typically benign (non-cancerous) but can cause significant health problems due to their location and growth. The most common type of tumor associated with NF2 are schwannomas, which arise from Schwann cells that form the myelin sheath around nerves. While schwannomas can occur on any nerve, they are particularly prevalent on the vestibular nerves, which are responsible for hearing and balance, leading to the development of bilateral vestibular schwannomas (also known as acoustic neuromas).

NF2 is a progressive condition, meaning that symptoms and tumor growth can worsen over time. The specific symptoms and their severity can vary greatly from person to person, even within the same family, due to the complex nature of genetic mutations and their effects. Early diagnosis and ongoing monitoring are crucial for managing NF2 and mitigating its potential complications.

What Causes NF2?

The root cause of Neurofibromatosis type 2 lies in genetic mutations. Specifically, NF2 is caused by changes (mutations) in the NF2 gene. This gene is located on chromosome 22 and provides instructions for making a protein called merlin (also known as schwannomin). Merlin plays a critical role in the regulation of cell growth and division, acting as a tumor suppressor. It helps to keep cells from growing and dividing too rapidly or in an uncontrolled way.

When the NF2 gene is mutated, the merlin protein is either not produced, or it is produced in a non-functional form. This loss of merlin function disrupts the normal control of cell growth, leading to the excessive proliferation of cells and the formation of tumors, primarily schwannomas, meningiomas, and ependymomas.

Genetic Inheritance of NF2

NF2 is an autosomal dominant genetic disorder. This means that a person only needs to inherit one copy of the mutated NF2 gene from either parent to develop the condition. If a parent has NF2, each of their children has a 50% chance of inheriting the mutated gene and developing the disorder.

However, it's important to note that approximately 50% of individuals diagnosed with NF2 have what are called 'de novo' mutations. This means that the mutation occurred spontaneously in the egg or sperm cell that formed the child, or very early in the child's embryonic development. In these cases, neither parent has NF2, and the mutation is not inherited. This 'new' mutation then becomes the cause of NF2 in that individual, and they can pass it on to their own children with a 50% chance.

Common Manifestations and Symptoms

The hallmark of NF2 is the development of tumors, primarily affecting the nervous system. The most frequent and often earliest symptom is the development of bilateral vestibular schwannomas. These tumors grow on the vestibular nerves, which connect the inner ear to the brain and are essential for hearing and balance.

Symptoms related to vestibular schwannomas can include:

• Progressive hearing loss, often starting in one ear and eventually affecting both.
• Tinnitus (ringing in the ears).
• Vertigo and dizziness.
• Impaired balance and coordination.

Beyond vestibular schwannomas, individuals with NF2 may develop other types of tumors, including:

• Meningiomas: Tumors that arise from the meninges, the membranes that surround the brain and spinal cord. These can occur anywhere in the central nervous system.
• Ependymomas: Tumors that develop in the ependymal cells lining the ventricles of the brain and the central canal of the spinal cord.
• Spinal cord tumors: Various types of tumors can form along the spinal cord.
• Schwannomas on other cranial and peripheral nerves: While the vestibular nerves are most common, other nerves can also be affected.

Other potential symptoms associated with NF2, depending on the location and size of tumors, can include facial nerve weakness, visual disturbances (due to optic nerve or other cranial nerve involvement), headaches, and neurological deficits if tumors press on the brain or spinal cord.

Diagnosis and Management

Diagnosing NF2 typically involves a combination of clinical examination, hearing tests (audiometry), balance tests, and imaging studies such as MRI (magnetic resonance imaging) and CT (computed tomography) scans. Genetic testing can also be used to confirm the diagnosis by identifying mutations in the NF2 gene.

Management of NF2 is focused on monitoring tumor growth, managing symptoms, and treating tumors when they cause significant problems. This often involves regular neurological examinations and imaging scans. Treatment options may include surgical removal of tumors if they are causing debilitating symptoms or pose a risk to neurological function. Radiation therapy may also be an option in certain cases. Research into new treatments, including targeted therapies and gene therapy, is ongoing.